[Skip to Navigation]
January 1996

Human Excimer Laser Keratectomy: Immunohistochemical Analysis of Healing

Author Affiliations

From the National Vision Research Institute, San Diego, Calif (Drs Anderson and Binder and Mr Rock), and Department of Ophthalmology, The University of Vermont, Burlington (Dr Vrabec).; Dr Binder is a participant in a clinical research trial using the Visx Excimer Laser and directed by the Visx Co, Sunnyvale, Calif. Dr Vrabec is now affiliated with Valley Eye Associates, Appleton, Wis.

Arch Ophthalmol. 1996;114(1):54-60. doi:10.1001/archopht.1996.01100130050008

Objective:  To analyze human corneal responses to excimer laser by immunohistochemistry.

Methods:  Corneas cultured for 3 weeks after laser ablation or taken from patients 5 to 16 months after laser treatment were exposed to antibodies to β4 integrin; types VII, IV, and III collagen; fibronectin; type I procollagen; and prolyl 4-hydroxylase. Antibody distributions were compared with those of normal corneas and unablated regions of treated corneas.

Results:  After 3 weeks, distribution of β4 integrin and types VII and IV collagen was patchy; heavy deposits of fibronectin appeared subepithelially. Keratocytes stained for prolyl 4-hydroxylase and type I procollagen. With increasing postoperative time, fibronectin diminished, and β4 integrin and type VII collagen became linear; stromal staining of types III and IV collagen increased and then diminished.

Conclusions:  Components of basement membrane, attachment complexes, and stromal matrix are synthesized shortly after laser treatment. Changes in these elements persist for 16 months in the human cornea.

Add or change institution